A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy

References

• Arem, H.N., Nakyanjo, N., Kagaayi, J., Mulamba, J., Nakigozi, G., Serwadda, D., … Chang, L.W. (2011). Peer health workers and AIDS care in Rakai, Uganda: A mixed methods operations research evaluation of a cluster-randomized trial. AIDS Patient Care and STDs, 25, 719–724. doi:10.1089/apc.2010.0349
   PubMed Web of Science ®Google Scholar
• Bagenda, A., Barlow-Mosha, L., Bagenda, D., Sakwa, R., Fowler, M.G., & Musoke, P.M. (2011). Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda. Annals of Tropical Paediatrics, 31, 235–245. doi:10.1179/1465328111Y.000000002510.1179/1465328111Y.0000000025
   PubMed Web of Science ®Google Scholar
• Chesney, M.A., Ickovics, J.R., Chambers, D.B., Gifford, A.L., Neidig, J., Zwickl, B., & Wu, A.W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12, 255–266. doi:10.1080/0954012005004289110.1080/09540120050042891
   PubMed Web of Science ®Google Scholar
• Cohen, C.J., Colson, A.E., Sheble-Hall, A.G., McLaughlin, K.A., & Morse, G.D. (2007). Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study. HIV Clinical Trials, 8, 19–23. doi:10.1310/hct0801-1910.1310/hct0801-19
   PubMed Web of Science ®Google Scholar
• Cook, P.F., Sousa, K.H., Matthews, E.E., Meek, P.M., & Kwong, J. (2011). Patterns of change in symptom clusters with HIV disease progression. Journal of Pain and Symptom Management, 42, 12–23. doi: 10.1016/j.jpainsymman.2010.09.021
   PubMed Web of Science ®Google Scholar
• Danel, C., Moh, R., Minga, A., Anzian, A., Ba-Gomis, O., Kanga, C., … Anglaret, X. (2006). CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in West Africa (Trivacan ANRS 1269 trial): A randomised trial. The Lancet, 367, 1981–1989.10.1016/S0140-6736(06)68887-9
   PubMed Web of Science ®Google Scholar
• Di Mascio, M., Markowitz, M., Louie, M., Hogan, C., Hurley, A., Chung, C., … Perelson, A.S. (2003). Viral blip dynamics during highly active antiretroviral therapy. Journal of Virology, 77, 12165–12172. doi:10.1128/JVI.77.22.12165-12172.200310.1128/JVI.77.22.12165-12172.2003
   PubMed Web of Science ®Google Scholar
• Eron, J. (2008). Managing antiretroviral therapy: Changing regimens, resistance testing, and the risks from structured treatment interruptions. The Journal of Infectious Diseases, 197(Suppl. 3), S261–S271. doi:10.1086/53341810.1086/589703
   Google Scholar
• Fox, M.P., McCoy, K., Larson, B.A., Rosen, S., Bii, M., Sigei, C., … Simon, J.L. (2010). Improvements in physical wellbeing over the first two years on antiretroviral therapy in Western Kenya. AIDS Care, 22, 137–145. doi:10.1080/0954012090303936610.1080/09540120903038366
   PubMed Web of Science ®Google Scholar
• Friedland, G.H. (2006). HIV medication adherence. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 43(Suppl. 1), S3–S9.10.1097/01.qai.0000248333.44449.ea
   Google Scholar
• Gardner, E.M., Burman, W.J., Maravi, M.E., & Davidson, A.J. (2006). Durability of adherence to antiretroviral therapy on initial and subsequent regimens. AIDS Patient Care and STDs, 20, 628–636. doi:10.1089/apc.2006.20.62810.1089/apc.2006.20.628
   PubMed Web of Science ®Google Scholar
• Ickovics, J.R., & Meade, C.S. (2002). Adherence to antiretroviral therapy among patients with HIV: A critical link between behavioral and biomedical sciences. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 31, S98–S102.10.1097/00126334-200212153-00002
   Web of Science ®Google Scholar
• Johnson, M.O., Stallworth, T., & Neilands, T.B. (2003). The drugs or the disease? Causal attributions of symptoms held by HIV positive adults on HAART. AIDS and Behavior, 7, 109–117. doi:10.1023/a:102393802300510.1023/A:1023938023005
   PubMed Web of Science ®Google Scholar
• Lalezari, J.P., DeJesus, E., Northfelt, D.W., Richmond, G., Wolfe, P., Haubrich, R., … Delehanty, J. (2003). A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir, and efavirenz in non-nucleoside reverse transcriptase inhibitor-naïve HIV-infected adults. Antiviral Therapy, 8, 279–287.
   PubMed Web of Science ®Google Scholar
• Lemiale, F., & Korokhov, N. (2009). Lentiviral vectors for HIV disease prevention and treatment. Vaccine, 27, 25–26. doi:10.1016/j.vaccine.2009.01.055
   Web of Science ®Google Scholar
• Lundgren, J., Babiker, A., El-Sadr, W., Emery, S., Grund, B., Neaton, J., … Phillips, A. (2008). Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4+ cell counts and HIV RNA levels during follow-up. The Journal of Infectious Diseases, 197, 1145–1155. doi:10.1086/529523
   PubMed Web of Science ®Google Scholar
• Marhefka, S.L., Tepper, V.J., Brown, J.L., & Farley, J.J. (2006). Caregiver psychosocial characteristics and children’s adherence to antiretroviral therapy. AIDS Patient Care and STDs, 20, 429–437. doi:10.1089/apc.2006.20.42910.1089/apc.2006.20.429
   PubMed Web of Science ®Google Scholar
• McMahon, D., Lederman, M., Haas, D.W., Haubrich, R., Stanford, J., Cooney, E., … Mellors, J.W. (2001). Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naïve HIV-1-infected adults. Antiviral Therapy, 6, 105–114.
   PubMed Web of Science ®Google Scholar
• Mellins, C., Brackis-Cott, E., Dolezal, C., & Abrams, E. (2004). The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal, 23, 1035–1041.10.1097/01.inf.0000143646.15240.ac
   PubMed Web of Science ®Google Scholar
• Merzel, C., VanDevanter, N., & Irvine, M. (2008). Adherence to antiretroviral therapy among older children and adolescents with HIV: A qualitative study of psychosocial contexts. AIDS Patient Care and STDs, 22, 977–987. doi:10.1089/apc.2008.004810.1089/apc.2008.0048
   PubMed Web of Science ®Google Scholar
• Miramontes, H. (2001). Treatment fatigue. Journal of the Association of Nurses in AIDS Care, 12, 90–92.10.1016/S1055-3290(06)60164-7
   PubMedGoogle Scholar
• Miron, R.E., & Smith, R.J. (2010). Modelling imperfect adherence to HIV induction therapy. BMC Infectious Diseases, 10, 6. doi:10.1186/1471-2334-10-610.1186/1471-2334-10-6
   PubMed Web of Science ®Google Scholar
• Moher, D., Liberati, A., Tetzlaff, J., & Altman, DG., The PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med, 6, e1000097. doi:10.1371/journal.pmed1000097.
   PubMed Web of Science ®Google Scholar
• Noguera, A., Morén, C., Rovira, N., Sànchez, E., Garrabou, G., Nicolàs, M., … Fortuny, C. (2010). Evolution of mitochondrial DNA content after planned interruption of HAART in HIV-infected pediatric patients. AIDS Research and Human Retroviruses, 26, 1015–1018. doi:10.1089/aid.2009.027310.1089/aid.2009.0273
   PubMed Web of Science ®Google Scholar
• Ostrop, N.J., Hallett, K.A., & Gill, M.J. (2000). Long-term patient adherence to antiretroviral therapy. The Annals of Pharmacotherapy, 34, 703–709.10.1345/aph.19201
   PubMed Web of Science ®Google Scholar
• Pai, N.P., Lawrence, J., Reingold, A.L., & Tulsky, J.P. (2006). Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults. Cochrane Database of Systematic Reviews, 3, CD006148.
   PubMedGoogle Scholar
• Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., Squier, C., … Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.10.7326/0003-4819-133-1-200007040-00004
   PubMed Web of Science ®Google Scholar
• Pinzon-Iregui, M., Beck-Sague, C., & Malow, R. (2013). Disclosure of their HIV status to infected children: A review of the literature. Journal of Tropical Pediatrics, 59, 84–89. doi:10.1093/tropej/fms05210.1093/tropej/fms052
   PubMed Web of Science ®Google Scholar
• Ruane, P., Alas, B., Ryan, R., Perniciaro, A., & Witek, J. (2010). A 48-week pilot study switching suppressed patients to darunavir/ritonavir and etravirine from enfuvirtide, protease inhibitor(s), and non-nucleoside reverse transcriptase inhibitor(s). AIDS Research and Human Retroviruses, 26, 1215–1219. doi:10.1089/aid.2009.0285
   PubMed Web of Science ®Google Scholar
• Ruane, P.J., Parenti, D.M., Margolis, D.M., Shepp, D.H., Babinchak, T.J., Van Kempen, A.S., … Hernandez, J.E. (2003). Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavirenz, followed by the lamivudine/zidovudine/abacavir triple nucleoside tablet plus efavirenz in treatment-naïve HIV-infected adults. HIV Clinical Trials, 4, 231–243.
   PubMed Web of Science ®Google Scholar
• Saitoh, A., Foca, M., Viani, R.M., Heffernan-Vacca, S., Vaida, F., Lujan-Zilbermann, J., … Spector, S.A. (2008). Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infection. Pediatrics, 121, e513–e521. doi:10.1542/peds.2007-108610.1542/peds.2007-1086
   PubMed Web of Science ®Google Scholar
• Skiest, D.J., Krambrink, A., Su, Z., Robertson, K.R., & Margolis, D.M. (2008). Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: Results of ACTG 5170. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 49, 377–383. doi:10.1097/QAl.0b013e31818cde2110.1097/QAI.0b013e31818cde21
   PubMed Web of Science ®Google Scholar
• Thompson, I., Bidgood, P., Petróczi, A., Denholm-Price, J., & Fielder, M. (2009). An alternative methodology for the prediction of adherence to anti HIV treatment. AIDS Research and Therapy, 6, 9. doi:10.1186/1742-6405-6-9
   PubMedGoogle Scholar
• Van Dyk, A.C. (2010). Treatment adherence following national antiretroviral rollout in South Africa. African Journal of AIDS Research, 9, 235–247. doi:10.2989/16085906.2010.53017710.2989/16085906.2010.530177
   PubMed Web of Science ®Google Scholar